Research Article
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
Figure 1
Survival analysis for patients stratified according to the MDACC score. (a) Overall survival analysis. (b) Time to first therapy analysis.
(a) |
(b) |